YAP/TAZ-CDC42 signaling regulates vascular tip cell migration M Sakabe, J Fan, Y Odaka, N Liu, A Hassan, X Duan, P Stump, L Byerly, ... Proceedings of the National Academy of Sciences 114 (41), 10918-10923, 2017 | 175 | 2017 |
Protothecosis: report of a case with 20-year follow-up, and review of previously published cases JR Todd, JW King, A Oberle, T Matsumoto, Y Odaka, M Fowler, RS Pore, ... Medical Mycology, 1-17, 2012 | 97 | 2012 |
Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells W Chen, L Liu, Y Luo, Y Odaka, S Awate, H Zhou, T Shen, S Zheng, Y Lu, ... Cancer prevention research 5 (5), 778-787, 2012 | 90 | 2012 |
Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells X Han, B Xu, CS Beevers, Y Odaka, L Chen, L Liu, Y Luo, H Zhou, ... Carcinogenesis 33 (4), 868-875, 2012 | 80 | 2012 |
Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression Y Luo, L Liu, D Rogers, W Su, Y Odaka, H Zhou, W Chen, T Shen, ... Neoplasia 14 (3), 228-237, 2012 | 79 | 2012 |
An opsin 5–dopamine pathway mediates light-dependent vascular development in the eye MTT Nguyen, S Vemaraju, G Nayak, Y Odaka, ED Buhr, N Alonzo, U Tran, ... Nature cell biology 21 (4), 420-429, 2019 | 67 | 2019 |
Adaptive thermogenesis in mice is enhanced by opsin 3-dependent adipocyte light sensing G Nayak, KX Zhang, S Vemaraju, Y Odaka, ED Buhr, A Holt-Jones, ... Cell reports 30 (3), 672-686. e8, 2020 | 62 | 2020 |
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells Y Odaka, B Xu, Y Luo, T Shen, C Shang, Y Wu, H Zhou, S Huang Carcinogenesis 35 (1), 192-200, 2014 | 62 | 2014 |
Medical phycology 2017 JR Todd, T Matsumoto, R Ueno, J Murugaiyan, A Britten, JW King, ... Medical mycology 56 (suppl_1), S188-S204, 2018 | 57 | 2018 |
Cancer‐specific targeting of an adenovirus‐delivered herpes simplex virus thymidine kinase suicide gene using translational control JM Mathis, BJ Williams, DA Sibley, JL Carroll, J Li, Y Odaka, S Barlow, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006 | 52 | 2006 |
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control MA Stoff-Khalili, AA Rivera, A Nedeljkovic-Kurepa, A DeBenedetti, XL Li, ... Breast cancer research and treatment 108, 43-55, 2008 | 51 | 2008 |
Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8) Y Odaka, A Mally, LT Elliott, S Meyers Oncogene 19 (32), 3584-3597, 2000 | 44 | 2000 |
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage S Palaniyandi, Y Odaka, W Green, F Abreo, G Caldito, A De Benedetti, ... Gene therapy 18 (3), 275-282, 2011 | 40 | 2011 |
Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death G Nayak, Y Odaka, V Prasad, AF Solano, EJ Yeo, S Vemaraju, ... Development 145 (12), dev154898, 2018 | 36 | 2018 |
Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A T Shen, C Shang, H Zhou, Y Luo, M Barzegar, Y Odaka, Y Wu, S Huang Genes & cancer 8 (3-4), 505, 2017 | 32 | 2017 |
Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs A Strat, L Gao, T Utsuki, B Cheng, S Nuthalapaty, JM Mathis, Y Odaka, ... Nucleic acids research 34 (13), 3803-3810, 2006 | 25 | 2006 |
Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature A Muley, Y Odaka, IP Lewkowich, S Vemaraju, TP Yamaguchi, ... PLoS One 12 (8), e0181549, 2017 | 20 | 2017 |
Murine rVEGF164b, an Inhibitory VEGF Reduces VEGF‐A‐Dependent Endothelial Proliferation and Barrier Dysfunction W Cromer, MH Jennings, Y Odaka, J Michael Mathis, J Steven Alexander Microcirculation 17 (7), 536-547, 2010 | 19 | 2010 |
eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival B Siegele, C Cefalu, N Holm, G Sun, J Tubbs, C Meschonat, Y Odaka, ... Journal of Surgical Research 148 (1), 83-89, 2008 | 18 | 2008 |
Cryptotanshinone activates p38/jnk and inhibits erk1/2 leading to caspase-independent cell death in tumor cells. Cancer Prev. Res. 2012; 5: 778–787. doi: 10.1158/1940-6207 W Chen, L Liu, Y Luo, Y Odaka, S Awate, H Zhou, T Shen, S Zheng, Y Lu, ... CAPR-11-0551.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 2019 | 16 | 2019 |